412 related articles for article (PubMed ID: 38299591)
21. Role and mechanisms of autophagy in alcohol-induced liver injury.
Chao X; Ding WX
Adv Pharmacol; 2019; 85():109-131. PubMed ID: 31307584
[TBL] [Abstract][Full Text] [Related]
22. Alcohol-Related Liver Disease: Basic Mechanisms and Clinical Perspectives.
Liu SY; Tsai IT; Hsu YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068269
[TBL] [Abstract][Full Text] [Related]
23. Experimental models of fatty liver diseases: Status and appraisal.
Wang H; Shen H; Seo W; Hwang S
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37378635
[TBL] [Abstract][Full Text] [Related]
24. Alcoholic and Non-Alcoholic Liver Diseases: Promising Molecular Drug Targets and their Clinical Development.
Thapa K; Grewal AS; Kanojia N; Rani L; Sharma N; Singh S
Curr Drug Discov Technol; 2021; 18(3):333-353. PubMed ID: 31965945
[TBL] [Abstract][Full Text] [Related]
25. Roles of the complement system in alcohol-induced liver disease.
Zhou Y; Yuan G; Zhong F; He S
Clin Mol Hepatol; 2020 Oct; 26(4):677-685. PubMed ID: 33053939
[TBL] [Abstract][Full Text] [Related]
26. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
27. Alcoholic liver disease: pathogenesis and new therapeutic targets.
Gao B; Bataller R
Gastroenterology; 2011 Nov; 141(5):1572-85. PubMed ID: 21920463
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs in alcoholic liver disease.
Szabo G; Satishchandran A
Semin Liver Dis; 2015 Feb; 35(1):36-42. PubMed ID: 25632933
[TBL] [Abstract][Full Text] [Related]
29. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association.
Petta S; Craxì A
Curr Pharm Des; 2010; 16(6):741-52. PubMed ID: 20388084
[TBL] [Abstract][Full Text] [Related]
31. Targeting inflammation for the treatment of alcoholic liver disease.
Xu MJ; Zhou Z; Parker R; Gao B
Pharmacol Ther; 2017 Dec; 180():77-89. PubMed ID: 28642119
[TBL] [Abstract][Full Text] [Related]
32. Role of mitochondria in alcoholic liver disease.
Nassir F; Ibdah JA
World J Gastroenterol; 2014 Mar; 20(9):2136-42. PubMed ID: 24605012
[TBL] [Abstract][Full Text] [Related]
33. Microbiota, Liver Diseases, and Alcohol.
Cassard AM; Gérard P; Perlemuter G
Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840806
[TBL] [Abstract][Full Text] [Related]
34. Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.
Ranjbarian T; Schnabl B
Semin Liver Dis; 2023 Aug; 43(3):311-322. PubMed ID: 37527781
[TBL] [Abstract][Full Text] [Related]
35. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
[TBL] [Abstract][Full Text] [Related]
36. Key Events Participating in the Pathogenesis of Alcoholic Liver Disease.
Magdaleno F; Blajszczak CC; Nieto N
Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28134813
[TBL] [Abstract][Full Text] [Related]
37. Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH).
Arab JP; Roblero JP; Altamirano J; Bessone F; Chaves Araujo R; Higuera-De la Tijera F; Restrepo JC; Torre A; Urzua A; Simonetto DA; Abraldes JG; Méndez-Sánchez N; Contreras F; Lucey MR; Shah VH; Cortez-Pinto H; Bataller R
Ann Hepatol; 2019; 18(3):518-535. PubMed ID: 31053546
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis, Early Diagnosis, and Therapeutic Management of Alcoholic Liver Disease.
Kong LZ; Chandimali N; Han YH; Lee DH; Kim JS; Kim SU; Kim TD; Jeong DK; Sun HN; Lee DS; Kwon T
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159489
[TBL] [Abstract][Full Text] [Related]
39. Alcoholic-related liver disease: pathogenesis, management and future therapeutic developments.
Argemi J; Ventura-Cots M; Rachakonda V; Bataller R
Rev Esp Enferm Dig; 2020 Nov; 112(11):869-878. PubMed ID: 33054302
[TBL] [Abstract][Full Text] [Related]
40. Emerging Roles of SIRT1 in Alcoholic Liver Disease.
Ren R; Wang Z; Wu M; Wang H
Int J Biol Sci; 2020; 16(16):3174-3183. PubMed ID: 33162823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
